Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
18.98
-0.48 (-2.47%)
At close: Jul 29, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,1106,7613,6563,7166,4656,688
Market Cap Growth
-2.82%84.94%-1.61%-42.53%-3.33%-3.43%
Enterprise Value
6,8516,4433,4423,0555,3915,318
Last Close Price
18.9818.059.769.9217.2618.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.1354.8028.2432.5276.29165.12
PB Ratio
6.417.713.202.773.873.65
P/TBV Ratio
7.219.023.693.344.574.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.4752.2226.5926.7463.61131.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.430.460.360.280.170.16
Net Debt / Equity Ratio
-0.23-0.35-0.39-0.42-0.58-0.65
Net Debt / EBITDA Ratio
-8.721.301.871.862.734.19
Net Debt / FCF Ratio
-10.211.202.321.422.242.08
Asset Turnover
0.220.070.070.050.030.02
Inventory Turnover
1.361.581.911.421.471.91
Quick Ratio
2.492.212.812.654.643.76
Current Ratio
3.542.453.092.905.073.95
Return on Equity (ROE)
0.31%-26.56%-16.21%-21.83%-20.38%-13.36%
Return on Assets (ROA)
0.36%-9.59%-8.76%-9.45%-10.08%-7.95%
Return on Capital Employed (ROCE)
0.70%-22.30%-19.50%-19.60%-18.70%-15.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.05%-3.96%-5.51%-8.85%-5.52%-3.89%
FCF Yield
0.36%-3.79%-5.23%-10.67%-6.64%-8.53%
Buyback Yield / Dilution
-0.42%0.17%0.24%-2.69%-0.79%-25.23%